News

Bedfont® Scientific Limited iCOquit® Smokerlyzer® features in award winning app to aid in smoking cessation. Erika Bloom, Ph.D., Director of Product and Research at WayBetter, won the Digital Health Tech Madness Champion Award at the Society of Behavioral Medicine’s (SBM)...

Families and four-legged friends walked among the bluebells to make a difference for Heart of Kent Hospice. On Sunday, May 4th, Bedfont® teamed up with joint headline sponsors NewMed Limited and participated in this year's Bluebell Walk, hosted by Heart...

The latest UK asthma guidelines1 have identified how Fractional exhaled Nitric Oxide (FeNO) testing fits into the diagnosis and ongoing management of asthma. The guidelines are based on the latest clinical evidence, cost-effectiveness, and cost-effective modelling, so they are strongly...

Asthma  is one of the most common long-term health conditions, so why does access to diagnosis and treatment still depend on where you live, who you see, or even your ethnicity? To mark World Asthma Day, we spoke with Carol...

Bedfont® Scientific Limited promotes FeNO testing for asthma management. Research from Asthma + Lung UK has found a significant rise in Accident and Emergency (A&E) visits from people experiencing breathing issues such as asthma. Asthma + Lung UK is a...

How FeNO testing with the NObreath® can aid an early asthma diagnosis in children. As the world prepares to observe World Health Day on April 7th, 2025, Bedfont® Scientific Limited highlights the importance of early and accurate asthma diagnosis with...